Sign inSubmit
ArticleArticle metrics
Research Article · Open access · Published 15 August 2018

Outcomes and Risk Factors Associated with Drug Resistant Tuberculosis in Rural Eastern Cape, South Africa

Carine Bokop Fotso1, Sandeep D. Vasaikar1 & Teke Apalata1

American Journal of Infectious Diseases, Volume 14, Issue 2, pp. 69–76 · doi.org/10.3844/ajidsp.2018.69.76

9,536 accesses4,679 downloads2 citations (Crossref)Journal metrics
Cite Check for updates

Abstract

With the emergence of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) strains of Mycobacterium tuberculosis, Tuberculosis (TB) has become an even greater threat in South Africa (SA). The study sought to investigate the resistance pattern of anti-TB drugs in M. tuberculosis as well as to determine the associated risk factors and outcomes for MDR-TB and XDR-TB. A descriptive study was conducted in 2 sub-districts of Eastern Cape province. Laboratory testing on sputum samples was done using genotypic and phenotypic methods. Data related to risk factors and outcomes were collected. SPSS v.22 was used for statistical analyses. 224 patients were enrolled (33.9% HIV negative and 66.1% HIV positive). Of 224 TB isolates obtained, 196 (87.5%) were MDR-TB (including 23 rifampicin mono-resistant isolates), 2 (0.9%) were isoniazid mono-resistant and 26 (11.6%) were Pre-XDR and XDR-TB. Of 196 MDR-TB patients, 143 (72.9%) had a favourable outcome post anti-TB therapy as compared to 17(65.4%) XDR-TB patients out of 26; but this difference was not statistically significant (OR = 1.5; CI: 0.6 – 3.4; ρ = 0.27). Whilst 118 (68.6%) out of 172 MDR-TB cases were newly diagnosed, previous exposure to anti-TB therapy was found to be a significant risk factor for developing XDR-TB (OR = 2.5; CI = 1.1 – 5.9; ρ = 0.023).Despite that 34 (26.2%) out of 130 new drug-resistant (DR)-TB patients completed their therapy, only 17 (13.1%) were declared cured as compared to 23 (33.8%) cured patients among the previously treated group (ρ<0.0001).In contrary, 9 (13.2%) cases of relapse and 11 (16.2%) defaulters were found among the previously treated DR-TB patients as compared to new cases [1 (0.8%) relapse versus 11 (8.5%) defaulters, respectively] on therapy (ρ<0.0001). High rates of DR-TB among treatment-naive patients, compounded with prevalent cases of relapses and defaulters among previously treated patients, raise the importance of DR-TB acquisition through direct transmission rather than the evolution of resistance.

Licence and reuse

Open access. This article is licensed under a Creative Commons Attribution 3.0 Licence (CC BY 3.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Fotso, C. B., Vasaikar, S. D. & Apalata, T. (2018). Outcomes and Risk Factors Associated with Drug Resistant Tuberculosis in Rural Eastern Cape, South Africa. American Journal of Infectious Diseases, 14(2), 69–76. https://doi.org/10.3844/ajidsp.2018.69.76

Licence
CC BY 3.0
Issue
Volume 14, Issue 2
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
Outcomes and Risk Factors Associated with Drug Resistant Tuberculosis in Rural Eastern Cape, South AfricaAmerican Journal of Infectious Diseases · Volume 14, Issue 2 · pp. 69–76 · CC BY 3.0Download